Triple
T16484368
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Orano |
E400399
|
entity |
| Predicate | hasSubsidiary |
P254
|
FINISHED |
| Object |
Orano Med
Orano Med is a nuclear medicine company specializing in the development of targeted alpha therapies for cancer treatment.
|
E1217030
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d883813098819084f5409539723b59 |
elicitation | completed |
| NER | batch_69e32e05bf448190947b9da15fd29d0a |
ner | completed |
| NED1 | batch_6a005820790c819088d953eeea09328d |
ned_source_triple | completed |
| NED2 | batch_6a0059b5a1f8819089caefc121246739 |
ned_description | completed |
| NEDg | batch_6a0059126e588190b531c145f3c155b4 |
nedg | completed |
Created at: April 10, 2026, 5:13 a.m.